MX375993B - Tratamiento o prevencion de anemia en mamiferos no humanos preñados. - Google Patents
Tratamiento o prevencion de anemia en mamiferos no humanos preñados.Info
- Publication number
- MX375993B MX375993B MX2017005419A MX2017005419A MX375993B MX 375993 B MX375993 B MX 375993B MX 2017005419 A MX2017005419 A MX 2017005419A MX 2017005419 A MX2017005419 A MX 2017005419A MX 375993 B MX375993 B MX 375993B
- Authority
- MX
- Mexico
- Prior art keywords
- human mammal
- blood haemoglobin
- pregnant non
- increasing
- less
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se relaciona con un complejo de hierro carbohidrato para su uso en un método para incrementar la concentración de hemoglobina sanguínea en un mamífero no humano preñado, en donde al mamífero no humano preñado que tiene un nivel de hemoglobina sanguínea de 105 g/L o menos, se administra una o más dosis de complejo de hierro carbohidrato que comprende una cantidad de hierro elemental de 1800 mg o más por dosis. El método se relaciona con los efectos adicionales de la reducción de crías mortinatas de un mamífero no humano preñado que tiene un nivel de hemoglobina sanguínea de 105 g/L o menos, el incremento de la concentración de hemoglobina sanguínea de las camadas de cría dentro de 3 días desde el nacimiento y/o el destete, o el incremento del tamaño de la camada en una paridad subsiguiente de un mamífero no humano que tiene un nivel de hemoglobina sanguínea de 105 g/L o menos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201470654 | 2014-10-27 | ||
| PCT/DK2015/050328 WO2016066172A1 (en) | 2014-10-27 | 2015-10-27 | Treatment or prevention of anaemia in pregnant non-human mammals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017005419A MX2017005419A (es) | 2017-11-30 |
| MX375993B true MX375993B (es) | 2025-03-07 |
Family
ID=54360839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017005419A MX375993B (es) | 2014-10-27 | 2015-10-27 | Tratamiento o prevencion de anemia en mamiferos no humanos preñados. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11040059B2 (es) |
| EP (2) | EP3212182B1 (es) |
| JP (1) | JP6680777B2 (es) |
| CN (3) | CN113559115A (es) |
| BR (1) | BR112017008709A2 (es) |
| CA (1) | CA2965722C (es) |
| DK (1) | DK3212182T3 (es) |
| ES (1) | ES2743223T3 (es) |
| HU (1) | HUE045092T2 (es) |
| LT (1) | LT3212182T (es) |
| MX (1) | MX375993B (es) |
| PH (1) | PH12017500646B1 (es) |
| PL (1) | PL3212182T3 (es) |
| PT (1) | PT3212182T (es) |
| RS (1) | RS59240B1 (es) |
| RU (1) | RU2712211C2 (es) |
| WO (1) | WO2016066172A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12017500646B1 (en) * | 2014-10-27 | 2023-09-13 | Pharmacosmos Holding As | Treatment or prevention of anaemia in pregnant non-human mammals |
| WO2018005913A1 (en) * | 2016-06-30 | 2018-01-04 | Vonnahme Kimberly A | Method for improving the quality and quantity of offspring in mammals |
| AU2018328052C1 (en) | 2017-09-11 | 2025-12-18 | Pharmacosmos Holding A/S | Iron complex compounds for therapeutic use |
| EP3473268A1 (en) * | 2017-10-20 | 2019-04-24 | IDT Biologika GmbH | Combined preparation for parenteral use |
| WO2020089227A1 (en) | 2018-10-29 | 2020-05-07 | Pharmacosmos Holding A/S | Treating iron deficiency with ferric carboxymaltose |
| WO2026017897A1 (en) | 2024-07-18 | 2026-01-22 | Malian Biologicals Gmbh | Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105791A (en) | 1961-07-20 | 1963-10-01 | Richardson Merrell Inc | Method of preventing the development of iron deficiency anemia in suckling pigs |
| US3259500A (en) * | 1961-10-11 | 1966-07-05 | Kentucky Res Foundation | Method for inhibiting anemia in young pigs by feeding the sow an iron agent |
| US4076803A (en) | 1976-03-15 | 1978-02-28 | Ashmead H H | Synergistic combination of metal proteinates with beta-chlorovinyl dialkyl phosphates |
| DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| WO2002085134A1 (en) * | 2001-04-24 | 2002-10-31 | Lonza Ltd. | Method of enhancing reproductive performance in sows |
| RU2274003C2 (ru) | 2004-03-02 | 2006-04-20 | Станислав Людвигович Люблинский | Способ комплексной переработки крови сельскохозяйственных животных для получения биологически активного вещества с противоанемическими свойствами на основе гемоглобина, биологически активное вещество с противоанемическими свойствами (варианты) и продукт, его содержащий (варианты). |
| DE102007054794A1 (de) | 2007-11-13 | 2009-05-14 | Agilan Gmbh | Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen |
| EP2411053B1 (en) * | 2009-03-25 | 2016-11-30 | Pharmacosmos Holding A/s | A stable iron oligosaccharide compound |
| DK2675475T3 (en) | 2011-02-17 | 2015-09-14 | Boehringer Ingelheim Vetmed | NEW EUROPEAN PRRSV TRIAL |
| PH12017500646B1 (en) * | 2014-10-27 | 2023-09-13 | Pharmacosmos Holding As | Treatment or prevention of anaemia in pregnant non-human mammals |
-
2015
- 2015-10-27 PH PH1/2017/500646A patent/PH12017500646B1/en unknown
- 2015-10-27 PL PL15787128T patent/PL3212182T3/pl unknown
- 2015-10-27 CN CN202110410139.3A patent/CN113559115A/zh active Pending
- 2015-10-27 ES ES15787128T patent/ES2743223T3/es active Active
- 2015-10-27 WO PCT/DK2015/050328 patent/WO2016066172A1/en not_active Ceased
- 2015-10-27 BR BR112017008709A patent/BR112017008709A2/pt not_active Application Discontinuation
- 2015-10-27 CA CA2965722A patent/CA2965722C/en active Active
- 2015-10-27 JP JP2017522471A patent/JP6680777B2/ja not_active Expired - Fee Related
- 2015-10-27 RU RU2017118319A patent/RU2712211C2/ru active
- 2015-10-27 CN CN202110407403.8A patent/CN113476471A/zh active Pending
- 2015-10-27 EP EP15787128.6A patent/EP3212182B1/en not_active Not-in-force
- 2015-10-27 US US15/522,466 patent/US11040059B2/en not_active Expired - Fee Related
- 2015-10-27 EP EP19181718.8A patent/EP3603632A1/en not_active Withdrawn
- 2015-10-27 PT PT15787128T patent/PT3212182T/pt unknown
- 2015-10-27 RS RSP20190966 patent/RS59240B1/sr unknown
- 2015-10-27 MX MX2017005419A patent/MX375993B/es active IP Right Grant
- 2015-10-27 HU HUE15787128A patent/HUE045092T2/hu unknown
- 2015-10-27 CN CN201580058214.7A patent/CN107206017B/zh not_active Expired - Fee Related
- 2015-10-27 LT LTEP15787128.6T patent/LT3212182T/lt unknown
- 2015-10-27 DK DK15787128.6T patent/DK3212182T3/da active
-
2021
- 2021-03-15 US US17/201,110 patent/US20210369763A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170333470A1 (en) | 2017-11-23 |
| CN113559115A (zh) | 2021-10-29 |
| RU2017118319A3 (es) | 2019-06-17 |
| PH12017500646A1 (en) | 2017-09-25 |
| LT3212182T (lt) | 2019-10-10 |
| RU2017118319A (ru) | 2018-11-29 |
| EP3603632A1 (en) | 2020-02-05 |
| PL3212182T3 (pl) | 2019-12-31 |
| EP3212182A1 (en) | 2017-09-06 |
| CN107206017B (zh) | 2021-05-07 |
| CA2965722C (en) | 2023-02-14 |
| BR112017008709A2 (pt) | 2017-12-26 |
| MX2017005419A (es) | 2017-11-30 |
| CN113476471A (zh) | 2021-10-08 |
| US20210369763A1 (en) | 2021-12-02 |
| HUE045092T2 (hu) | 2019-12-30 |
| EP3212182B1 (en) | 2019-06-26 |
| JP2017535537A (ja) | 2017-11-30 |
| PH12017500646B1 (en) | 2023-09-13 |
| ES2743223T3 (es) | 2020-02-18 |
| PT3212182T (pt) | 2019-07-29 |
| CA2965722A1 (en) | 2016-05-06 |
| RU2712211C2 (ru) | 2020-01-27 |
| RS59240B1 (sr) | 2019-10-31 |
| US11040059B2 (en) | 2021-06-22 |
| WO2016066172A1 (en) | 2016-05-06 |
| CN107206017A (zh) | 2017-09-26 |
| DK3212182T3 (da) | 2019-08-05 |
| JP6680777B2 (ja) | 2020-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX375993B (es) | Tratamiento o prevencion de anemia en mamiferos no humanos preñados. | |
| PH12016500773A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section | |
| PH12016500762A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
| PH12018501325A1 (en) | Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion | |
| PH12016500868A1 (en) | Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children | |
| PH12019501010A1 (en) | Arginase inhibitor combination therapies | |
| MY189333A (en) | Pharmaceutical composition for use in prevention and/or treatment of disease that develops or progresses as a result of decrease or loss of activity of blood coagulation factor viii and/or activated blood coagulation factor viii | |
| TN2017000468A1 (en) | TREATMENT OF BETA-THALASSEMIA USING ACTRIl LIGAND TRAPS. | |
| MY179927A (en) | Genetically modified non-human animals expressing human epo | |
| MX2016000364A (es) | Metodos para tratar o prevenir afecciones oftalmologicas. | |
| JOP20190008A1 (ar) | علاج ومنع اضطرابات النوم | |
| MX384751B (es) | Tratamiento del cáncer con una combinación de plinabulina y taxano. | |
| JP2016516751A5 (es) | ||
| JP2016519107A5 (es) | ||
| NZ721500A (en) | Use of halogen compounds for the treatment and prevention of heart attack and ischemic injury | |
| GB201205739D0 (en) | Treatment of acute inflammation in the respiratory tract | |
| MX2016010892A (es) | Agente para suprimir el progreso de o para mejorar la enfermedad renal cronica. | |
| PH12017500617A1 (en) | Dosage regimen for pegylated interferon | |
| PH12016501101A1 (en) | Veliparib in combination with carboplatin for the treatment of triple negative breast cancer | |
| ECSP19000167A (es) | Métodos y composiciones para el tratamiento de la hipercalciuria y la nefrolitiasis | |
| BR112015020566A2 (pt) | moduladres de ror gama | |
| LIN et al. | THE CLINICAL EXPERIENCE OF MINOR BLUEGREEN DRAGON DECOCTION IN TREAT-MENT OF CHRONIC COUGH | |
| Cockerill | Gemcitabine/mitomycin | |
| Carpenter | Bruising: case report | |
| Folger | Ulcerative oesophagitis: case report |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |